Development and Characterization of a New Endoscopic Drug-Eluting Platform With Proven Efficacy in Acute and Chronic Experimental Colitis

Background and Aims: Mucosal lesions refractory to biological treatments represent unmet needs in patients with inflammatory bowel disease (IBD) that require new treatment modalities. We developed and characterized a new endoscopic drug-eluting hydrogel (CoverGel) with proven efficacy in acute and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Bon, Ignacio, Cano-Sarabia, Mary, de la Ossa, Napoleon, Bartolí, Ramon, Lorenzo-Zúñiga, Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468471/
https://www.ncbi.nlm.nih.gov/pubmed/32974357
http://dx.doi.org/10.3389/fmed.2020.00415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468471/
https://www.ncbi.nlm.nih.gov/pubmed/32974357
http://dx.doi.org/10.3389/fmed.2020.00415

Ejemplares similares